Venezuela will receive 6.2 million doses of COVID-19 vaccines through the global COVAX initiative in the coming days, Reuters news agency reported on Monday.
President Nicolas Maduro had reportedly given COVAX an "ultimatum" to send the doses or return the funds Venezuela has already paid.
This announcement comes after the GAVI alliance, which co-runs the COVAX facility along with the World Health Organisation (WHO), said in early July 2021 that COVAX had received payments from Venezuela after the country's officials said some payments were blocked by a bank due to US sanctions.
According to the Pan-American Health Organisation (PAHO), the regional arm of the WHO, Venezuela will receive doses of Chinese pharmaceutical company Sinopharm (HKG:1099) and biopharmaceutical Sinovac Biotech Ltd(Nasdaq:SVA) vaccines through the initiative.
The country has so far been administering Sinopharm, Russia's Sputnik-V and Cuba's Abdala COVID-19 vaccines, Reuters added.
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
Alzinova AB reports positive final Phase 1b results for ALZ-101 in Alzheimer's
Primrose Bio launches Prima RNApols ExTend RNA polymerase for long-template mRNA manufacturing
Merck's CAPVAXIVE approved by EC for pneumococcal disease prevention
Sanofi secures FDA fast track designation for chlamydia vaccine candidate
Anixa Biosciences secures US patent allowance for ovarian cancer vaccine
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
Everest Medicines' EVM14 IND application receives US FDA approval
Clover Biopharmaceuticals' SCB-1019 IND application receives US FDA approval
Centivax partners with Emery Pharma on universal flu vaccine
Avance Biosciences registers with CLIA program
GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine
hVIVO secures GBP2m contract for final stage of hMPV characterisation study
EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine